Treatment with BIX-01294, an EHMT2-specific inhibitor, similarly suppressed growth and inhibited the migration/invasion of RCC cell lines, confirming the functional role of EHMT2 in RCC progression. The gene discussed is EHMT2; the disease is renal cell adenocarcinoma.